KdT Ventures is the standard for early-stage frontier science investing.
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A; Series B
Portfolio 44
Date | Name | Website | Total Raised | Location |
10.01.2024 | Perceptive | perceptive.io | - | United Sta... |
19.07.2023 | SURGE Ther... | surgetx.com | $58M | - |
04.03.2023 | Elo Life S... | elolife.com | $20.5M | - |
04.03.2023 | Nosis Bio | nosisbio.com | - | - |
04.03.2023 | Syenex | syenex.com | - | United Sta... |
04.03.2023 | Aperiam Bi... | aperiambio.com | $9M | United Sta... |
04.03.2023 | Character | characterbio.com | $18M | United Sta... |
04.03.2023 | Cyberdonti... | cyberdontics.io | - | - |
01.03.2023 | EQUII | equii.com | $6M | United Sta... |
01.02.2023 | Dimension ... | dimensioninx.com | $15.18M | United Sta... |
Show more
Persons 8
Date | First Name | Last Name | Title | Location | |||
- | Ketan | Yerneni | Principal | linkedin.c... | - | k***n@kdtv... | - |
- | Phil | Grayeski | Partner | linkedin.c... | - | p**l@kdtvc... | - |
- | Yusuf | Uddin, PhD | Head of Ta... | linkedin.c... | - | y***f@kdtv... | - |
- | Blair | Willette | Senior Fel... | linkedin.c... | - | B***r@kdtv... | - |
- | Mack | Healy | Partner | linkedin.c... | - | m**k@kdtvc... | - |
- | Rima | Chakrabart... | Partner | linkedin.c... | - | r**a@kdtvc... | - |
- | Cain | McClary, M... | Founder an... | linkedin.c... | - | c**n@kdtvc... | - |
- | Patrick | Malone, MD... | Principal | linkedin.c... | - | P*****k@kd... | - |
Mentions in press and media 22
Date | Title | Description |
17.10.2024 | KdT Ventures Closes Fourth Fund, at over $100M | KdT Ventures, an Austin, Texas-based venture capital firm backing frontier science companies, closed its fourth fund, at over $100m. The fund, the firm’s largest fund to date, follows KdT’s previous $80 million Fund III which was announced ... |
26.01.2024 | Motif Neurotech Raises $18.75M for Implantable Device for Treatment-Resistant Depression | What You Should Know: – Motif Neurotech, a pioneer in minimally-invasive bioelectronics for mental health, announced today an impressive $18.75 million Series A funding round. Led by Arboretum Ventures, the investment saw participation from... |
18.01.2022 | BREAKING: Faeth raises $20m from Khosla, AgFunder to battle cancer with food | Disclosure: AFN’s parent company, AgFunder, is an investor in Faeth Therapeutics. Faeth Therapeutics, a startup developing precision nutrition solutions to help fight cancer, has raised $20 million in seed funding in a round led by Khosla V... |
18.01.2022 | Faeth raises $20m from Khosla, AgFunder to battle cancer with food | Disclosure: AFN’s parent company, AgFunder, is an investor in Faeth Therapeutics. Faeth Therapeutics, a startup developing precision nutrition solutions to help fight cancer, has raised $20 million in seed funding in a round led by Khosla V... |
17.09.2021 | Debut Biotech is creating next-gen ingredients through ‘cell-free biomanufacturing’ | With climate change and its environmental consequences upon us, many companies are turning to more ‘natural’ alternatives to the chemical-based ingredients commonly used in food, beverages, cosmetics, and therapeutics. One such company is S... |
16.09.2021 | 54gene Closes $25M Series B to Advance Global Drug Discovery Capabilities | |
14.09.2021 | BREAKING: Nitrogen fixer Andes scores $15m from Bayer, Wilbur-Ellis to move into carbon capture | Andes, a Chilean-founded, US-based ag biotech startup, has raised $15 million in Series A funding. The round was co-led by the VC arms of Bayer and Wilbur-Ellis – Leaps by Bayer and Cavallo Ventures. Existing investors Endurance and KdT Ven... |
14.09.2021 | Nitrogen fixer Andes scores $15m from Bayer, Wilbur-Ellis to move into carbon capture | Andes, a Chilean-founded, US-based ag biotech startup, has raised $15 million in Series A funding. The round was co-led by the VC arms of Bayer and Wilbur-Ellis – Leaps by Bayer and Cavallo Ventures. Existing investors Endurance and KdT Ven... |
12.08.2021 | Debut Biotech Raises $22.6M Series A to Commercialize High-Value Ingredients from Proprietary Cell-Free Biomanufacturing Platform | By overcoming the limitations of cell-based fermentation, Debut Biotech produces high-value ingredients rapidly and more sustainably. SAN DIEGO (PRWEB) August 12, 2021 Debut Biotech, a next generation biomanufacturing platform harnessing ce... |
28.03.2021 | KdT Ventures Raises $50 Million Fund to Invest in Early-Stage Science Companies | Austin-based KdT Ventures announced a new $50 million fund to back early-stage science companies. |
Show more